TB

14 registered clinical trials studyying TB — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure) NCT07164742	Johns Hopkins University	N/A
Recruiting	Pharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects NCT06701110	Shanghai Jiatan Pharmatech Co., Ltd	Phase 1
Unknown	Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2) NCT05405296	Foundation for Innovative New Diagnostics, Switzerland	—
Active Not Recruiting	Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA NCT04298905	Johns Hopkins University	N/A
Completed	Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Managem NCT04645836	Xi'an Jiaotong University	N/A
Unknown	Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI) NCT04673227	Thomayer University Hospital	—
Unknown	Childhood Acute Illness and Nutrition Network NCT03208725	University of Oxford	—
Terminated	Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients NCT01055145	Seoul National University Hospital	Phase 3
Completed	A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both NCT00480558	University of Oxford	Phase 1
Withdrawn	Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuber NCT00424684	University of Pittsburgh	N/A
Completed	Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines NCT00480454	University of Oxford	Phase 1
Completed	Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine NCT00654316	University of Oxford	Phase 1
Completed	A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers NCT00480714	University of Oxford	N/A
Completed	A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers NCT00480688	University of Oxford	Phase 1